1
/
of
1
Dr.Hepo
PANTHENOL QUINTESSENCE 100MG - 20 non-coated tablets
PANTHENOL QUINTESSENCE 100MG - 20 non-coated tablets
Regular price
$33.50 USD
Regular price
Sale price
$33.50 USD
Unit price
/
per
Taxes included.
Couldn't load pickup availability
Without a doctor's recommendation, the product can be used as a supportive treatment for mucosal involvement in inflammation of the upper respiratory tract and oral mucosa.
On the recommendation of a doctor, the product can be used as a supportive treatment of mucosal involvement in inflammation of the upper respiratory tract (inflammation of the pharynx, bronchi, trachea, larynx, inflammation of the nasal mucosa), as well as after-treatment after tonsil surgery, treatment of pantothenic acid deficiency symptoms that cannot be managed by simple diet adjustment, such as tingling and pain in the fingers and soles of the foot ("burning-feetsyndrome", symptoms of burning feet); These symptoms are provoked by a lack of pantothenic acid.
On the recommendation of a doctor, the product can be used as a supportive treatment of mucosal involvement in inflammation of the upper respiratory tract (inflammation of the pharynx, bronchi, trachea, larynx, inflammation of the nasal mucosa), as well as after-treatment after tonsil surgery, treatment of pantothenic acid deficiency symptoms that cannot be managed by simple diet adjustment, such as tingling and pain in the fingers and soles of the foot ("burning-feetsyndrome", symptoms of burning feet); These symptoms are provoked by a lack of pantothenic acid.
Panthenol Quintesence contains dexpanthenol as the active substance, which is well absorbed from the digestive tract and is converted in the body to pantothenic acid, known as vitamin B. Pantothenic acid is necessary for a number of metabolic processes and its deficiency causes a number of pathological manifestations, especially on the skin and mucous membranes, there is also a decrease in overall resistance, Appears weakness and nervous breakdowns.
Panthenol Quintessence can be used by adults and adolescents from 14 years of age.
If you do not feel better within 7 days or if you get worse, you need to consult a doctor.
The carton pack contains 20 tablets.
Dosage and method of use
Adults and adolescents from 14 years of age:
Supportive treatment of mucosal affections: 200 to 400 mg dexpanthenol daily, corresponding to 2 to 4 tablets of Panthenol Quintesence per day in divided doses of 1 tablet. The tablets are allowed to dissolve in the mouth.
The minimum interval between doses should be 2 hours.
The minimum interval between doses should be 2 hours.
Although there is no evidence for a toxic effect of dexpanthenol in humans, the use of Panthenol Quintesence is not recommended in children under 14 years of age due to the high doses.
Treatment of pantothenic acid deficiency conditions (for example, burning feet syndrome):
1 tablet of Panthenol Quintessence per day (equivalent to 100 mg of dexpanthenol), swallowed whole.
Paediatric population:
The use of the product in this case should be supported by a careful assessment of the benefit/risk ratio by the doctor.
Method of administration and duration of treatment:
For the treatment of mucosal affections, Panthenol Quintessence tablets are allowed to slowly dissolve in the mouth.
In the treatment of pantothenic acid deficiency conditions, the tablet is swallowed with a little liquid, independently of the meal.
The duration of treatment depends on the clinical picture.
In the treatment of pantothenic acid deficiency conditions, the tablet is swallowed with a little liquid, independently of the meal.
The duration of treatment depends on the clinical picture.
Composition
Each tablet contains: 100 mg of dexpanthenol.
Excipients are: colloidal anhydrous silica, sucrose, saccharin sodium, gelatin, magnesium stearate, potato starch, glycerol 85%, talc, purified water.
Contraindication
Read the package leaflet carefully.
Do not take if you are hypersensitive to the active substance or to any of the excipients.
The use of this product during pregnancy and lactation should be based on an assessment of the benefit/risk ratio by the attending physician.
Share
